pembrolizumab
merck
['crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'pembro', 'rectal', 'colorectal']
 technically with keynote-177 data out and approval of pembrolizumab for unresectable or metastatic colorectal cancer. so for advanced rectal cancer, insurance should cover #immunotherapy. #asco22 #crcsm 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22